- Lobbying
- John AND Kevin AND Brennan
Lobbying Arrangements Results for 'John Kevin Brennan'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Seek congressional support for Medicare coverage for anti-obesity drugs. |
Orexigen Therapeutics, Inc.
|
FaegreBD Consulting | |||
Details Access to care for individuals with asthma and allergies. |
Allergy & Asthma Network
|
FaegreBD Consulting | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Click Therapeutics, Inc.
|
BLUEBIRD STRATEGIES | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
MindMaze Inc.
|
BLUEBIRD STRATEGIES | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Luminopia, Inc.
|
BLUEBIRD STRATEGIES | |||
Details Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. Medicare/Medicaid coverage report language. Mental health prescription digital therapeutics coverage. |
Pear Therapeutics
|
BLUEBIRD STRATEGIES | |||
Details Federal funding for NIH research. |
Global Down Syndrome Foundation
|
BLUEBIRD STRATEGIES | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Boehringer Ingelheim USA Corporation
|
BLUEBIRD STRATEGIES | |||
Details PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests. Draft legislation to regulate clinical labs under CLI... |
Myriad Genetics, Inc.
|
Faegre Baker Daniels Consulting | |||
Details Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Fe... |
Myotonic
|
BLUEBIRD STRATEGIES | |||
Details Opposition to prescription drug importation legislation |
Alliance for Safe Online Pharmacies (ASOP)
|
Faegre Baker Daniels Consulting (f/k/a FaegreBD Consulting) | |||
Details Increase awareness of clinical use of FDA cleared prescription digital therapeutics. Medicare coverage of FDA cleared prescription digital therapeutics. |
Pear Therapeutics
|
Faegre Baker Daniels Consulting | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Otsuka America Pharmaceutical, Inc.
|
BLUEBIRD STRATEGIES | |||
Details CDC Infection Disease Public Health & Epidemiology Funding. Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization. Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PAS... |
The Peggy Lillis Foundation
|
BLUEBIRD STRATEGIES | |||
Details Legislation to regulate clinical labs under CLIA and FDA. Medicaid coverage for mental health genetic testing. VA access for mental health genetic testing. Medicaid precision medicine legislation. |
Myriad Genetics, Inc.
|
BLUEBIRD STRATEGIES | |||
Details Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act and issues related to sepsis treatment and antibiotic stewardship. CMS coverage for kidney transplant diagnostics. |
Thermo Fisher Scientific Inc.
|
BLUEBIRD STRATEGIES | |||
Details Federal funding for NIH research. |
Faegre Baker Daniels Consulting (on behalf of Global Down Syndrome Foundation)
|
BLUEBIRD STRATEGIES | |||
Details Increase federal support for research on child abuse and neglect Appropriations for research on child abuse and neglect Enhancing federal funding for research on child abuse and neglect |
Kempe Foundation
|
Faegre Baker Daniels Consulting | |||
Details Drug shortages Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019 Fiscal Year 2019 labor HHS appropriations legislation; issues relat... |
Thermo Fisher Scientific
|
Faegre Baker Daniels Consulting | |||
Details Increasing funding for Myotonic Dystrophy research; Fiscal Year 2019 Labor and HHS appropriations. Fiscal Year 2019 Defense appropriations legislation; Peer Review Medical Research Program and Cong... |
Myotonic Dystrophy Foundation
|
Faegre Baker Daniels Consulting | |||
Details Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome |
Global Down Syndrome Foundation
|
Faegre Baker Daniels Consulting | |||
Details PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests. FDA draft guidance to regulate laboratory developed tes... |
Myriad Genetic Laboratories, Inc.
|
Faegre Baker Daniels Consulting | |||
Details Vaccine policy issues |
NOVAVAX
|
Faegre Baker Daniels Consulting | |||
Details Fiscal Year 2020 funding for Alzheimer's disease research and policies to enhance NIH Alzheimer's research. S. 1126 - Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of ... |
USAGAINST ALZHEIMER'S
|
Faegre Baker Daniels Consulting | |||
Details HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy. Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation o... |
Immune Deficiency Foundation
|
Faegre Baker Daniels Consulting | |||
Details Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety |
Alliance for Safe Online Pharmacies (ASOP)
|
Faegre Baker Daniels Consulting | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES | |||
Details Lobbied to prevent new line speed waivers and reduce existing waivers to beef, poultry, or hog slaughter plants. Lobbied against further expanding the program of putting plant employees, not inspe... |
AMERICAN FED OF GOVERNMENT EMPLOYEES, AFL-CIO
|
in-house lobbying |